Imugene highlights azer-cel progress as trial patient enters remission

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) is drawing fresh attention to its experimental cancer therapy azer-cel after a ...

Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Multiple Sclerosis News Today

Trial of CAR T-cell therapy for progressive MS now recruiting in US

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...
Business Insider

Wall Street's top cannabis analyst just leveled a stark warning. Here are the 3 stocks to avoid, and 1 to buy instead.

Wall Street just leveled a stark warning against investing in Canadian cannabis stocks and said investors should shift their attention to emerging US names, instead. In a Monday morning note, Cowen ...
Yahoo Finance

Azer Cel Milestone Broadens TG Therapeutics Autoimmune Pipeline And Valuation Story

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. TG Therapeutics and Precision BioSciences reached a clinical ...

Imugene reports strong early response rates for azer-cel in lymphoma study

Clinical-stage immuno-oncology company Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has reported encouraging early response ...